Archive: 18/11/2015
Nivolumab in NSCLC: Indication of major added benefit for under 75-year-olds
Nivolumab is an anti-tumour drug from the group of monoclonal antibodies. It has been available since June 2015 under the trade name Opdivo for adults with advanced melanoma, and since July 2015 under the trade name Nivolumab ...
Nov 18, 2015
Research yields potential treatment approach for glycogen storage disease
Researchers from the Duke-NUS Graduate Medical School Singapore (Duke-NUS) and Duke Medicine have identified a potential treatment strategy for an often-fatal inherited glycogen storage disease.
Nov 18, 2015
Hospital ordered to pay $10M for late meningitis diagnosis
Children's Hospital of Philadelphia has been ordered to pay $10 million to the mother of a boy whose bacterial meningitis wasn't promptly diagnosed despite multiple emergency room visits.
Nov 18, 2015
Coconut oil shows promise in the prevention of deadly bloodstream infection
Coconut oil may be effective at combating infection with Candida albicans, according to a study published November 18th in the American Society for Microbiology's new open access journal mSphere. The study found that coconut ...
Nov 18, 2015